The effect of glutaraldehyde cross-linker on structural and biocompatibility properties of collagen-chondroitin sulfate electrospun mat
Source abstract
Abstract
The collagen with glycosaminoglycans such as chondroitin sulfate can potentially be used in many soft tissue engineering applications since the scaffolds mimic the structure and biological function of native extracellular matrix (ECM). In this study, we designed woven and aligned collagen-chondroitin sulfate mats by electrospinning method. The electrospun mats cross-linked with glutaraldehyde vapor at different times, the cross-linked mats became more biostable and were resistant to collagenase degradation. Cellular results with corneal epithelial cells showed that bioviability was reduced in cross-linked mats with glutaraldehyde. Characteristics such as high surface area of nanofibers, biodegradability, and orientation of fibers may maximize cell-ECM interaction and promote tissue regeneration faster than other conventional scaffolds. The cross-linked collagen-chondroitin sulfate electrospun mats can be used in tissue engineering, especially in soft tissue regeneration.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Collagen: Extraction and Characterization · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Studies in Biotechnology, University of Mysore, Mysuru, India
Department of Biomaterials Engineering, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran
Brien Holden Eye Research Center, and Center for Ocular Regeneration, L. V. Prasad Eye Institute, Hyderabad, India
Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
References (37)
Show source-provided references
1. 10.5772/858110.5772/8581 ↗
2. 10.1021/bm015533u10.1021/bm015533u ↗
3. 10.1242/jcs.02382010.1242/jcs.023820 ↗
4. 10.1016/j.ydbio.2009.10.02610.1016/j.ydbio.2009.10.026 ↗
5. 10.1016/j.addr.2003.08.00210.1016/j.addr.2003.08.002 ↗
6. Ehrmann RL · J Nat Cancer Inst · 1956 · 16 · 1375
7. 10.5772/2298110.5772/22981 ↗
8. 10.1002/marc.v30:710.1002/marc.v30:7 ↗
9. Li WJ · Nanotechnol Life Sci · 2006 · 9 · 135
10. 10.3390/jfb403016210.3390/jfb4030162 ↗
11. 10.1016/S1359-0294(03)00004-910.1016/S1359-0294(03)00004-9 ↗
12. Liu H · J Nanomater · 2013 · 495708 · 11
13. 10.1016/j.bbrc.2007.12.07710.1016/j.bbrc.2007.12.077 ↗
14. 10.1016/j.mattod.2013.06.00510.1016/j.mattod.2013.06.005 ↗
15. 10.1080/00914037.2015.107490710.1080/00914037.2015.1074907 ↗
16. 10.1166/jbn.2013.163910.1166/jbn.2013.1639 ↗
17. 10.1016/j.biomaterials.2006.01.01510.1016/j.biomaterials.2006.01.015 ↗
18. 10.1163/092050609X1245741839665810.1163/092050609X12457418396658 ↗
19. Zhang YZ · Int J Nanomed · 2007 · 2 · 623
20. Potaros T · Nat Sci · 2009 · 43 · 584
21. Tang J · BioMed Res Int · 2015 · 139476 · 8
22. Yamada SH · BioMed Res Int · 2014 · 302932 · 8
23. 10.1016/j.msec.2006.05.01010.1016/j.msec.2006.05.010 ↗
24. 10.1016/j.cej.2007.09.00910.1016/j.cej.2007.09.009 ↗
25. 10.1021/bm050318p10.1021/bm050318p ↗
26. 10.1126/science.286.5447.216910.1126/science.286.5447.2169 ↗
27. 10.1159/00002806410.1159/000028064 ↗
28. 10.1021/bm060964410.1021/bm0609644 ↗
29. 10.1016/S0142-9612(00)00423-310.1016/S0142-9612(00)00423-3 ↗
30. Vandrovcova M · Physiol Res · 2011 · 60 · 79710.33549/physiolres.931994 ↗
31. 10.1016/S0079-6425(00)00018-910.1016/S0079-6425(00)00018-9 ↗
32. 10.1167/iovs.07-159910.1167/iovs.07-1599 ↗
33. 10.1166/jbn.2014.183110.1166/jbn.2014.1831 ↗
34. Sujithra S · Int J Eng Technol (IJET) · 2013 · 5 · 2181
35. Qureshi IZ · Int J Biol Biomol Agric Food Biotechnol Eng · 2010 · 4 · 710
36. Baradaran-Rafii A · Curr Eye Res · 2015 · 1019004 · 326
37. 10.1016/S0142-9612(03)00541-610.1016/S0142-9612(03)00541-6 ↗